Rebecca R Vanderpool Selected Research

Vascular Remodeling

1/2022	Mineralocorticoid receptor antagonist treatment of established pulmonary arterial hypertension improves interventricular dependence in the SU5416-hypoxia rat model.
2/2016	SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rebecca R Vanderpool Research Topics

Disease

16	Pulmonary Arterial Hypertension 05/2022 - 01/2013
9	Pulmonary Hypertension 01/2020 - 05/2010
5	Hypoxia (Hypoxemia) 05/2022 - 01/2011
5	Heart Failure 01/2020 - 02/2016
3	Vascular Diseases (Vascular Disease) 01/2022 - 10/2014
2	Right Ventricular Hypertrophy 05/2022 - 11/2017
2	Hypertrophy 05/2022 - 01/2021
2	Vascular Remodeling 01/2022 - 02/2016
2	Heart Diseases (Heart Disease) 01/2020 - 11/2016
2	Insulin Resistance 01/2020 - 02/2016
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 02/2016
2	Hyperglycemia 01/2020 - 02/2016
1	Cardiomyopathies (Cardiomyopathy) 01/2023
1	Neoplasms (Cancer) 01/2023
1	Stroke (Strokes) 05/2022
1	Atrial Remodeling 01/2021
1	Heart Arrest (Cardiac Arrest) 01/2021
1	Bradycardia 01/2021
1	Cardiac Arrhythmias (Arrythmia) 01/2021
1	Ventricular Fibrillation 01/2021
1	Glucose Intolerance 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2018
1	Diabetes Mellitus 01/2018
1	Hemolysis 01/2018
1	Disease Progression 01/2016

Drug/Important Bio-Agent (IBA)

4	Semaxinib (SU5416)IBA 05/2022 - 02/2016
3	treprostinil FDA Link 05/2022 - 10/2018
3	Epoprostenol (Prostacyclin)FDA LinkGeneric 05/2022 - 01/2017
3	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 02/2016
2	Leptin ReceptorsIBA 01/2020 - 02/2016
2	MonocrotalineIBA 01/2020 - 01/2016
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2020 - 02/2016
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 07/2017
2	Sodium NitriteIBA 11/2016 - 02/2016
2	NitritesIBA 11/2016 - 02/2016
1	Phosphotransferases (Kinase)IBA 01/2023
1	CreatinineIBA 01/2023
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2022
1	Mineralocorticoid Receptor AntagonistsIBA 01/2022
1	RelaxinIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Sulfhydryl Compounds (Thiols)IBA 01/2021
1	Dithiothreitol (Cleland's Reagent)IBA 01/2021
1	tetramethylpyrazineIBA 01/2020
1	beraprostIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Thymidine Monophosphate (TMP)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	Blood Glucose (Blood Sugar)IBA 01/2018
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2018
1	Soluble Guanylyl CyclaseIBA 01/2018
1	BAY 54-6544IBA 01/2018
1	p38 Mitogen-Activated Protein KinasesIBA 11/2017
1	Arginine (L-Arginine)FDA Link 07/2017
1	LigandsIBA 01/2017
1	ErbB Receptors (EGF Receptor)IBA 01/2017
1	Protein Kinases (Protein Kinase)IBA 02/2016
1	NitratesIBA 02/2016
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 02/2016
1	AMP-Activated Protein KinasesIBA 02/2016
1	Sirtuin 3IBA 02/2016
1	15-phenyl-beta-methylpentadecanoic acidIBA 10/2014
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2013
1	CollagenIBA 01/2013
1	rho-Associated KinasesIBA 01/2011
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 05/2010
1	Serotonin (5 Hydroxytryptamine)IBA 05/2010

Therapy/Procedure

10	Therapeutics 01/2023 - 11/2016
1	Precision Medicine 01/2022